Ovizep 5mg Injection

Therapeutic Area: Diabetes & Obesity Management

Generic Name: Tirzepatide 5mg

Indications: 1. Type 2 Diabetes Mellitus: To improve glycaemic control in adults as an adjunct to diet and exercise

2. Obesity or Overweight: As an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with obesity (BMI ≥30 kg/m²) or overweight (BMI ≥27 kg/m²) with at least one weight-related comorbidity (e.g., hypertension, dyslipidaemia)

Available as:
– 2.5mg, 5mg and 7.5mg prefilled syringe

Ovizep 2.5mg Injection

Therapeutic Area: Diabetes & Obesity Management

Generic Name: Tirzepatide 2.5mg

Indications: 1. Type 2 Diabetes Mellitus: To improve glycaemic control in adults as an adjunct to diet and exercise

2. Obesity or Overweight: As an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with obesity (BMI ≥30 kg/m²) or overweight (BMI ≥27 kg/m²) with at least one weight-related comorbidity (e.g., hypertension, dyslipidaemia)

Available as:
– 2.5mg, 5mg and 7.5mg prefilled syringe

Ovizep 7.5mg Injection

Therapeutic Area: Diabetes & Obesity Management

Generic Name: Tirzepatide 7.5mg

Indications: 1. Type 2 Diabetes Mellitus: To improve glycaemic control in adults as an adjunct to diet and exercise

2. Obesity or Overweight: As an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with obesity (BMI ≥30 kg/m²) or overweight (BMI ≥27 kg/m²) with at least one weight-related comorbidity (e.g., hypertension, dyslipidaemia)

Available as:
– 2.5mg, 5mg and 7.5mg prefilled syringe

Hemoflux 500 Injection